More on OPK

- Summary
- Chart
- Profile
- Historical


- Earnings
- Ratings (6.0 Score)
- Holders
- Event Driven Deals
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (1/28/22 *Est.)
- M&A (12/31/16 *Est)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

OPK Income Statement

Click line-items for a historical chart and %
Product sales 20.57M
Other revenue
Total Revenue 298.04M
Cost of goods sold, excluding amortization of intangible assets
Gross margin, excluding amortization of intangible assets
Operating expenses
Selling, general and administrative 124.85M
Research and development 24.42M
Other operating expenses, principally amortization of intangible assets
Total operating expenses 321.66M
Operating loss -23.62M
Other expense, net -2.97M
Loss before income taxes and investment loss -34.15M
Income tax (benefit) provision 19.99M
Loss before investment losses
Loss from investments in investees
Net loss
Preferred stock dividend
Net loss attributable to common Shareholders -14.98M
Loss per share, basic and diluted
Weighted average number of common shares outstanding, basic and diluted